Collaboration between acute and primary care to improve oral proton pump inhibitor prescribing in surgical patients

被引：0
|
作者：
Cristina, Coelho [1 ]
Yvonne, Semple [1 ]
机构：
[1] NHS Greater Glasgow & Clyde, Med Informat Pharm & Prescribing Support Unit, Glasgow, Lanark, Scotland
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2011年 / 20卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
3
引用
收藏
页码：661 / 662
页数：2
相关论文
共 50 条
  • [21] Developing shared care prescribing guidance for oral methotrexate - A collaborative approach between secondary and primary care to improve patient safety
    Johnson, Deborah
    Wonnacott, Karen
    Howes, Kath
    Parton, Simon
    Hajela, Vijay
    RHEUMATOLOGY, 2008, 47 : II142 - II143
  • [22] Predictors for inappropriate proton pump inhibitor use: observational study in primary care
    Koggel, Lieke Maria
    Lantinga, Marten Alexander
    Buchner, Frederike Leonie
    Drenth, Joost Paulus Hubertus
    Frankema, Jacqueline Sarah
    Heeregrave, Edwin Johannes
    Heringa, Mette
    Numans, Mattijs Everard
    Siersema, Peter Derk
    BRITISH JOURNAL OF GENERAL PRACTICE, 2022, 72 (725): : E899 - E906
  • [23] Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care
    Ahrens, D.
    Behrens, G.
    Himmel, W.
    Kochen, M. M.
    Chenot, J. -F.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (08) : 767 - 773
  • [24] The influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary care
    Larsen, Michael Due
    Schou, Mette
    Kristiansen, Anja Sparre
    Hallas, Jesper
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (07) : 859 - 865
  • [25] Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care
    Martin, RM
    Lim, AG
    Kerry, SM
    Hilton, SR
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (08) : 797 - 805
  • [26] The influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary care
    Michael Due Larsen
    Mette Schou
    Anja Sparre Kristiansen
    Jesper Hallas
    European Journal of Clinical Pharmacology, 2014, 70 : 859 - 865
  • [27] Risk of acute kidney injury in proton pump inhibitor naive patients
    Dyer, Summer
    Venker, Brett
    Lacro, Jonathan
    PHARMACOTHERAPY, 2017, 37 (12): : E190 - E190
  • [28] Predictors of Brand Name Proton Pump Inhibitor Prescribing From the National Ambulatory Medical Care Survey
    Gawron, Andrew J.
    Feinglass, Joseph
    Pandolfino, John E.
    Tan, Bruce K.
    Bove, Michiel
    Shintani-Smith, Stephanie
    GASTROENTEROLOGY, 2014, 146 (05) : S184 - S185
  • [29] Using a Systems Engineering Framework to Evaluate Proton Pump Inhibitor Prescribing in Critically Ill Patients
    Tischendorf, Jessica S.
    Knobloch, Mary J.
    Musuuza, Jackson S.
    Safdar, Nasia
    JOURNAL FOR HEALTHCARE QUALITY, 2020, 42 (04) : E39 - E49
  • [30] COMPARISON OF HEALTH CARE UTILIZATIONS BETWEEN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE WHO SWITCHED FROM A BRANDED PROTON PUMP INHIBITOR TO A GENERIC PROTON PUMP INHIBITOR AND VICE VERSA
    Xie, L.
    Baser, E.
    Wang, L.
    Baser, O.
    VALUE IN HEALTH, 2011, 14 (03) : A181 - A181
12345